Supplementary Figure S1 from Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase

Open Access

Publisher Website

31 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/1078-0432.22476569.v1

Abstract

Kaplan-Meier Plot Comparing PFS Among Patients With and Without Prior Rituximab

Keywords